Nulliparity and late-life first childbirth are associated with more aggressive breast cancer, according to Swedish researchers. Reuters Health Information
Only months after the FDA revoked its metastatic breast cancer indication, the agent improved response in the neoadjuvant setting in 2 trials. Medscape Medical News
Dr. Maurie Markman highlights the results of a surveillance study on the safety of the HPV vaccine in his latest video blog. Medscape Hematology-Oncology
Does tumor vascularity, or expression of vascular endothelial growth factor protein and its receptors, contribute to patient outcomes? Laboratory Investigation
Nearly one quarter of breast lesions deemed "indeterminate" on magnetic resonance imaging proved to be malignant at 6-month follow-up. Medscape Medical News